Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 12 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 11478430

    Implantable medical devices for extended release of therapeutic agents

    Nano Precision Medical, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  2. US 11479611

    HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer

    China Medical University Hospital · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  3. US 11471471

    Aqueous oral pharmaceutical suspension compositions

    ReveraGen BioPharma, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  4. US 11470861

    Preparation method and application of astaxanthin H1-, or H2- or J-aggregate water dispersion system

    OCEAN UNIVERSITY OF CHINA · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  5. US 11471509

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  6. US 11464830

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  7. US 11459564

    Modulation of frataxin expression

    The Board of Regents of the University of Texas System · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  8. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  9. US 11453861

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  10. US 11452782

    Liver-specific constructs factor VIII expression cassettes and methods of use thereof

    Sangamo Therapeutics, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  11. US 11453870

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  12. US 11446380

    Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  13. US 11447521

    Compounds and methods for modulating angiotensinogen expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  14. US 11435349

    CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs

    The Regents of the University of California · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  15. US 11427540

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  16. US 11421231

    Modulation of Huntington expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted

  17. US 11413240

    Methylene blue solution for the treatment of oral lesions

    The Board of Regents of the University of Texas System · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  18. US 11407990

    Fusion proteins and methods for site-directed genome editing

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  19. US 11400123

    Combination product for prophylaxis and treatment of irritable bowel syndrome

    PrecisionBiotics Group Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  20. US 11401506

    Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy

    Board nf Regents The Inivercitvof Texas Cvctom · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  21. US 11401320

    QTY FC fusion receptor proteins

    Avalon GloboCare Corp. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  22. US 11401341

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  23. US 11384355

    Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

    Arrowhead Pharmaceuticals, Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

  24. US 11384335

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.